Why and How We Developed Consensus Guidelines for Diabetes management in Cancer Patients (#115)

2:00 PM

Kathleen Steele

ADEA Oral Presentations - Quality Improvement and Service Delivery

Soluble urokinase plasminogen activator receptor (suPAR) levels and decline in estimated glomerular filtration rate (eGFR) in patients with diabetes (#31)

11:15 AM

Richard MacIsaac

ADS Clinical Orals - Renal & Foot Complications

Mixed Meal Testing: Effective Clinical Tool or Outdated Investigation? (#244)

2:00 PM

Stephanie Bond

ADS Clinical Poster Session - Nutrition

Audit of Diabetes Management Guidelines for the Cancer Centre during the Pilot Phase (#59)

4:15 PM

Peter G Colman

ADS Clinical Orals - Type 2 Therapies

A Comparison of Glycaemic Control in Adults and Adolescents With Type 1 Diabetes When Using a Closed Loop Insulin Delivery System Overnight Versus Sensor-Augmented Pump With Low Glucose Suspend At Home: A Randomised Crossover Study (#159)

9:00 AM

Amin Sharifi

ADS Clinical Orals - Type 1 Diabetes

Suboptimal overnight glucose control behaviours common in adults with Type 1 diabetes: An assessment tool and need for education. (#230)

2:00 PM

Alicia J Jenkins

ADS Clinical Poster Session - Type 1 Diabetes (general)

A comparison of GP and specialist diabetes clinic based adult Type 1 diabetes glucose self-care and control. (#236)

2:00 PM

Gary Kilov

ADS Clinical Poster Session - Therapy of type 1 diabetes